24-Hour Intraocular Pressure With Brinzolamide/Timolol Versus Brimonidine/Timolol
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The proposed crossover study will compare for the first time the quality of 24-hour
intraocular pressure control with the combination of travoprost and brinzolamide/timolol
compared with travoprost and brimonidine/timolol in glaucoma patients insufficiently
controlled with travoprost. This comparison may determine the real efficacy of the two fixed
combinations when added to the prostaglandin. The design of the proposed study should
facilitate a better understanding of the role of these medications in glaucoma management.